Daniel Kelly, MD


Department of Medicine


11-122 Smilow 

Visit the lab website here

The Kelly lab is interested in the mechanisms governing mitochondrial function and fuel metabolism in the developing and diseased heart. The long-term goal of our studies is to identify novel targets for novel metabolic modulator therapy aimed at heart failure in diabetic and non-diabetic patients.

Penn Cell Biology, Physiology, and Metabolism

Perelman School of Medicine at the University of Pennsylvania

© 2020 by Penn CPM. Proudly created with Wix.com